GILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)GILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)GILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)

GILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)

No trades
See on Supercharts

Key stats

Market capitalization
‪83.48 B‬USD
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income
Revenue
Shares float
Beta (1Y)
0.53

About GILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)

CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Founded
1987
ISIN
ARBCOM4601C4
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.